Literature DB >> 11165671

Airway goblet-cell mucus secretion.

A D Jackson1.   

Abstract

A mucus hypersecretory phenotype is a dominant characteristic of chronic airways diseases such as chronic bronchitis and asthma. This phenotype develops following chronic exposure of the respiratory tract to particulate matter, allergens, irritants and/or pathogens. The associated increase in the mucus-producing potential of the respiratory epithelium represents an innate host response that can be modulated by elements of the adaptive host response. Although elevation of mucus production is designed to protect the airways, increasing evidence suggests that in excess it can be detrimental to health. Considerable progress has been made over the past five years in understanding the mechanisms involved in the development and regulation of the hypersecretory phenotype. This progress has set the stage for the development of successful dedicated mucomodulatory strategies to counter the negative impact of excess mucus production in respiratory disease.

Entities:  

Mesh:

Year:  2001        PMID: 11165671     DOI: 10.1016/s0165-6147(00)01600-x

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  14 in total

1.  The recombinant C-terminus of the human MUC2 mucin forms dimers in Chinese-hamster ovary cells and heterodimers with full-length MUC2 in LS 174T cells.

Authors:  Martin E Lidell; Malin E V Johansson; Matthias Mörgelin; Noomi Asker; James R Gum; Young S Kim; Gunnar C Hansson
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

Review 2.  Airway mucus: From production to secretion.

Authors:  Olatunji W Williams; Amir Sharafkhaneh; Victor Kim; Burton F Dickey; Christopher M Evans
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

3.  Regulation of particulate matter-induced mucin secretion by transient receptor potential vanilloid 1 receptors.

Authors:  Hongmei Yu; Qi Li; Victor P Kolosov; Juliy M Perelman; Xiangdong Zhou
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

4.  Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development.

Authors:  Po-Nien Tsao; Shu-Chen Wei; Ming-Fang Wu; Miao-Tzu Huang; Hsien-Yi Lin; Ming-Cheng Lee; Kurt Ming-Chao Lin; I-Jong Wang; Vesa Kaartinen; Liang-Tung Yang; Wellington V Cardoso
Journal:  Development       Date:  2011-08       Impact factor: 6.868

Review 5.  The Role of Proprotein Convertases in Upper Airway Remodeling.

Authors:  Sang-Nam Lee; Joo-Heon Yoon
Journal:  Mol Cells       Date:  2022-06-30       Impact factor: 4.250

Review 6.  New insights into upper airway innate immunity.

Authors:  Benjamin M Hariri; Noam A Cohen
Journal:  Am J Rhinol Allergy       Date:  2016-09       Impact factor: 2.467

Review 7.  Therapy for chronic obstructive pulmonary disease in the 21st century.

Authors:  Louise E Donnelly; Duncan F Rogers
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  SPDEF regulates goblet cell hyperplasia in the airway epithelium.

Authors:  Kwon-Sik Park; Thomas R Korfhagen; Michael D Bruno; Joseph A Kitzmiller; Huajing Wan; Susan E Wert; Gurjit K Khurana Hershey; Gang Chen; Jeffrey A Whitsett
Journal:  J Clin Invest       Date:  2007-03-08       Impact factor: 14.808

9.  Multiple exposures to swine barn air induce lung inflammation and airway hyper-responsiveness.

Authors:  Chandrashekhar Charavaryamath; Kyathanahalli S Janardhan; Hugh G Townsend; Philip Willson; Baljit Singh
Journal:  Respir Res       Date:  2005-06-02

Review 10.  Macrophage heterogeneity in respiratory diseases.

Authors:  Carian E Boorsma; Christina Draijer; Barbro N Melgert
Journal:  Mediators Inflamm       Date:  2013-02-27       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.